Increased levels of the synaptic proteins PSD-95, SNAP-25, and neurogranin in the cerebrospinal fluid of patients with Alzheimer’s disease
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Increased levels of the synaptic proteins PSD-95, SNAP-25, and neurogranin in the cerebrospinal fluid of patients with Alzheimer’s disease
Authors
Keywords
-
Journal
Alzheimers Research & Therapy
Volume 14, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-04-23
DOI
10.1186/s13195-022-01002-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease: Current Evidence and Future Perspectives
- (2021) Donovan A. McGrowder et al. Brain Sciences
- The clinical promise of biomarkers of synapse damage or loss in Alzheimer’s disease
- (2020) Martí Colom-Cadena et al. Alzheimers Research & Therapy
- Learning and reaction times in mouse touchscreen tests are differentially impacted by mutations in genes encoding postsynaptic interacting proteins SYNGAP1 , NLGN3 , DLGAP1 , DLGAP2 and SHANK2
- (2020) Alexa E. Horner et al. GENES BRAIN AND BEHAVIOR
- Changes in synaptic proteins precede neurodegeneration markers in preclinical Alzheimer’s disease cerebrospinal fluid
- (2019) Alberto Lleó et al. MOLECULAR & CELLULAR PROTEOMICS
- SNAP-25 in Serum Is Carried by Exosomes of Neuronal Origin and Is a Potential Biomarker of Alzheimer’s Disease
- (2019) Cristina Agliardi et al. MOLECULAR NEUROBIOLOGY
- Emerging cerebrospinal fluid biomarkers in autosomal dominant Alzheimer's disease
- (2019) Suzanne E. Schindler et al. Alzheimers & Dementia
- Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease
- (2019) Sebastian Palmqvist et al. EMBO Molecular Medicine
- CSF synaptic protein concentrations are raised in those with atypical Alzheimer’s disease but not frontotemporal dementia
- (2019) Mica T. M. Clarke et al. Alzheimers Research & Therapy
- Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology
- (2018) Erik Portelius et al. ACTA NEUROPATHOLOGICA
- Longitudinal decreases in multiple cerebrospinal fluid biomarkers of neuronal injury in symptomatic late onset Alzheimer's disease
- (2018) Courtney L. Sutphen et al. Alzheimers & Dementia
- α-Synuclein oligomers induce early axonal dysfunction in human iPSC-based models of synucleinopathies
- (2018) Iryna Prots et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PSD95: A synaptic protein implicated in schizophrenia or autism?
- (2018) Austin A. Coley et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer’s disease
- (2018) Hua Zhang et al. Alzheimers Research & Therapy
- A Parallel Reaction Monitoring Mass Spectrometric Method for Analysis of Potential CSF Biomarkers for Alzheimer's Disease
- (2017) Gunnar Brinkmalm et al. Proteomics Clinical Applications
- Increased CSF neurogranin concentration is specific to Alzheimer disease
- (2016) Henrietta Wellington et al. NEUROLOGY
- C-terminal neurogranin is increased in cerebrospinal fluid but unchanged in plasma in Alzheimer's disease
- (2015) Ann De Vos et al. Alzheimers & Dementia
- PSD-95 family MAGUKs are essential for anchoring AMPA and NMDA receptor complexes at the postsynaptic density
- (2015) Xiaobing Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer’s disease
- (2014) Ann Brinkmalm et al. Molecular Neurodegeneration
- Bacterial Cytolysin during Meningitis Disrupts the Regulation of Glutamate in the Brain, Leading to Synaptic Damage
- (2013) Carolin Wippel et al. PLoS Pathogens
- Neuroinflammation and Synaptic Loss
- (2012) Jagadeesh S. Rao et al. NEUROCHEMICAL RESEARCH
- Postsynaptic degeneration as revealed by PSD-95 reduction occurs after advanced Aβ and tau pathology in transgenic mouse models of Alzheimer’s disease
- (2011) Charles Y. Shao et al. ACTA NEUROPATHOLOGICA
- pROC: an open-source package for R and S+ to analyze and compare ROC curves
- (2011) Xavier Robin et al. BMC BIOINFORMATICS
- A High-Confidence Human Plasma Proteome Reference Set with Estimated Concentrations in PeptideAtlas
- (2011) Terry Farrah et al. MOLECULAR & CELLULAR PROTEOMICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation